SCHEMBL8323641

SCHEMBL8323641

CCOC(=O)c1[nH]c(C)c(-c2nc(Nc3ccc(S(N)(=O)=O)cc3)ncc2CO)c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 5/20 0.46
CA1 P00915 3/20 0.46
CA9 Q16790 3/20 0.46
CDK2 P24941 10/20 0.42
CDK1 P06493 8/20 0.42
CDK7 P50613 3/20 0.42
CDK9 P50750 3/20 0.42
CCNT1 O60563 2/20 0.42
CCNH P51946 2/20 0.42
CCNB1 P14635 2/20 0.42
KDR P35968 7/20 0.42
CDK4 P11802 3/20 0.42
CCND1 P24385 1/20 0.42
CCNE1 P24864 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
MAPT P10636 2/20 0.41
NPC1 O15118 1/20 0.41
CCNA2 P20248 1/20 0.41
CCNA1 P78396 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14011222 0.83 CDK2 (0.59) CA2CA1CA9CDK2CDK4
SCHEMBL8323680 0.76 GAA (0.46) CDK2CDK7CDK9CCNT1CCNH
SCHEMBL8326253 0.74 KDR (0.50) CDK2CDK1CDK7CCNHKDR
SCHEMBL8317411 0.71 CDK2 (0.58) CDK2CDK1CDK7CDK9CCNT1
SCHEMBL8317365 0.69 CDK2 (0.60) CDK2CDK4MEN1KMT2AMAPT
SCHEMBL8317316 0.69 CDK2 (0.74) CDK2CDK4NPC1
SCHEMBL8316804 0.69 CDK4 (0.59) CDK2CDK4KMT2ANPC1
SCHEMBL8325791 0.69 CDK2 (0.56) CDK2KDRCDK4MEN1KMT2A
SCHEMBL28791529 0.66 KMT2A (0.80) CA2CA1CA9MEN1KMT2A
SCHEMBL24477620 0.64 CA2 (0.55) CA2CA1CA9CDK2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7456190-B2 Compositions useful as protein kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-11-25 US disclosed
US-7456190-B2 Compositions useful as protein kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-11-25 US disclosed
WO-2004083203-A1 COMPOSITIONS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-09-30 WO disclosed